Table 3.
Characteristics | Hormonal Replacement | Immunoactive Prophylaxis | Lactobacillus | Cranberry | Hyaluronic Acid | D-mannose |
---|---|---|---|---|---|---|
Data maturity | Solid | Solid | Poor | Poor | Poor | Poor |
Route of Administration | Vaginal | Oral | Oral | Oral | Endovesical Oral |
Oral |
Adverse Events | Vaginal discomfort, irritation, burning, itching | None | None | None | Burning during instillation (78%) | Diarrhea (<8%) |
EAU Guidelines on Urinary Tract Infections | Recommended for post-menopausal women (weak) | More effective than placebo (strong) | Further trials are needed before recommendation for or against its use | Contradictory results. No recommendation | No recommendation | Data indicative but not sufficient for recommendation |